Applied Materials (AMAT) Suffers a Larger Drop Than the General Market: Key Insights

Applied Materials fell 2.13% to $509.57, underperforming the S&P 500’s 0.47% decline, after shares had gained 11.05% ahead of the session. Analysts project November 12, 2026 quarterly EPS of $4.06, up 87.1% year over year, and revenue of $10.3 billion, up 51.4%; the consensus EPS estimate rose 0.16% over the past 30 days, and the stock carries a Zacks Rank of #1. Its forward P/E of 40.71 exceeds the industry’s 38.83, while the article provides no earnings results or explanation for the day’s decline.

Analysis

The one-day decline is a weak signal after AMAT’s recent outperformance; the more important setup is asymmetric event risk. The earnings growth embedded in forecasts is steep, while the cited 30-day EPS estimate increase is modest. That combination leaves the stock vulnerable to multiple compression if results merely meet expectations, especially given its valuation premium to the industry. Conversely, continued estimate upgrades and evidence that AI-related demand is broadening beyond a narrow set of leading-edge customers could support the premium.

Over the next 1–3 months, focus on estimate breadth and the November 12 report—not the daily tape. Verify order/backlog trends, customer mix, gross-margin trajectory, and management’s wafer-fab-equipment outlook. A second-order risk is that AI capex remains strong but concentrated, while weaker spending elsewhere or export restrictions offset the benefit; this could also pressure equipment peers such as Lam Research and KLA, though the article provides no evidence on their relative exposure. Over 6–18 months, the key question is whether current investment converts into durable customer spending rather than a capex peak. The bearish thesis is falsified by broad upward estimate revisions and guidance that supports demand and margins; the bullish case weakens if estimates turn down or guidance disappoints.

Key Decisions for Investors

• Do not trade the single-session underperformance as a standalone bearish catalyst; it may be routine profit-taking after the prior run-up.
• Avoid adding to AMAT ahead of earnings at current expectations. For existing tactical exposure, consider trimming or using a defined-risk hedge into the November 12 event rather than an outright short.
• Set an alert for estimate revisions and company commentary on orders, backlog, customer breadth, margins, and WFE outlook. Reassess if revisions broaden upward; reduce risk if estimates roll over or guidance fails to validate the growth embedded in forecasts.
• A relative-value short against Lam Research or KLA is only a watch item, not a recommendation: first compare valuation, estimate momentum, and order exposure to establish that AMAT is actually the weaker name.